BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alkhouli M, Noseworthy PA, Rihal CS, Holmes DR. Stroke Prevention in Nonvalvular Atrial Fibrillation. Journal of the American College of Cardiology 2018;71:2790-801. [DOI: 10.1016/j.jacc.2018.04.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Alkhouli M, Friedman PA. Ischemic Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. J Am Coll Cardiol 2019;74:3050-65. [PMID: 31865973 DOI: 10.1016/j.jacc.2019.10.040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
2 Alkhouli M, Nielsen-kudsk JE. The Case for Intracardiac Echo to Guide Left Atrial Appendage Closure. Interventional Cardiology Clinics 2022;11:153-8. [DOI: 10.1016/j.iccl.2021.11.007] [Reference Citation Analysis]
3 Goldhaber SZ, Piazza G. Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities. European Heart Journal 2019;40:1515-7. [DOI: 10.1093/eurheartj/ehz004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Alkhouli M. Stroke Prevention in Very Elderly Patients With Nonvalvular Atrial Fibrillation Revisited. Mayo Clin Proc 2021;96:13-5. [PMID: 33413808 DOI: 10.1016/j.mayocp.2020.11.012] [Reference Citation Analysis]
5 Holmes DR, Alkhouli M. Rebellious palpitations. Eur Heart J 2020;41:2902-3. [PMID: 32385490 DOI: 10.1093/eurheartj/ehaa261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Siddiqi TJ, Usman MS, Shahid I, Ahmed J, Khan SU, Ya'qoub L, Rihal CS, Alkhouli M. Utility of the CHA2DS2-VASc score for predicting ischaemic stroke in patients with or without atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol 2021:zwab018. [PMID: 33693717 DOI: 10.1093/eurjpc/zwab018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Alkhouli M, Sievert H, Rihal CS. Device Embolization in Structural Heart Interventions. JACC: Cardiovascular Interventions 2019;12:113-26. [DOI: 10.1016/j.jcin.2018.08.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
8 Hijazi M, Aljohani S, Alqahtani F, Chaker Z, Al Hajji M, Al Hallak A, Alkhouli M. Perception of the Risk of Stroke and the Risks and Benefits of Oral Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation: A Cross-Sectional Study. Mayo Clinic Proceedings 2019;94:1015-23. [DOI: 10.1016/j.mayocp.2018.08.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Rajiah P, Alkhouli M, Thaden J, Foley T, Williamson E, Ranganath P. Pre- and Postprocedural CT of Transcatheter Left Atrial Appendage Closure Devices. Radiographics 2021;41:680-98. [PMID: 33939541 DOI: 10.1148/rg.2021200136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chita DS, Tudor A, Christodorescu R, Buleu FN, Sosdean R, Deme SM, Mercea S, Pop Moldovan A, Pah AM, Docu Axelerad A, Docu Axelerad D, Dragan SR. MTHFR Gene Polymorphisms Prevalence and Cardiovascular Risk Factors Involved in Cardioembolic Stroke Type and Severity. Brain Sci 2020;10:E476. [PMID: 32722170 DOI: 10.3390/brainsci10080476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Barocelli F, Coli S, Crocamo A, Guidorossi A, Cattabiani MA, Preti F, Bosi D, Spaziani C, Lina D, Menozzi A, Solinas E, Pelà G, Vignali L. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding. J Cardiovasc Med (Hagerstown) 2020;21:583-91. [PMID: 32443136 DOI: 10.2459/JCM.0000000000000976] [Reference Citation Analysis]
12 Holmes DR, Alkhouli M, Reddy V. Left Atrial Appendage Occlusion for The Unmet Clinical Needs of Stroke Prevention in Nonvalvular Atrial Fibrillation. Mayo Clinic Proceedings 2019;94:864-74. [DOI: 10.1016/j.mayocp.2018.09.025] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 12.7] [Reference Citation Analysis]
13 Coll PP, Roche V, Olsen JS, Voit JH, Bowen E, Kumar M. The Prevention of Cardiovascular Disease in Older Adults. J Am Geriatr Soc 2020;68:1098-106. [DOI: 10.1111/jgs.16353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Fradley MG, Beckie TM, Brown SA, Cheng RK, Dent SF, Nohria A, Patton KK, Singh JP, Olshansky B. Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation 2021;144:e41-55. [PMID: 34134525 DOI: 10.1161/CIR.0000000000000986] [Reference Citation Analysis]
15 Escobar C, Camm AJ. Changing paradigms: from prevention of thromboembolic events to improved survival in patients with atrial fibrillation. Europace 2021;23:837-43. [PMID: 33221894 DOI: 10.1093/europace/euaa324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Munir MB, Khan MZ, Darden D, Pasupula DK, Balla S, Han FT, Reeves R, Hsu JC. Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedures in the United States. Heart Rhythm 2021;18:1508-15. [PMID: 34020049 DOI: 10.1016/j.hrthm.2021.05.017] [Reference Citation Analysis]
17 Holmes DR, Reddy VY, Gordon NT, Delurgio D, Doshi SK, Desai AJ, Stone JE, Kar S. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. Journal of the American College of Cardiology 2019;74:2878-89. [DOI: 10.1016/j.jacc.2019.09.064] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 13.7] [Reference Citation Analysis]
18 Freitas-Ferraz AB, Bernier M, O'Connor K, Beaudoin J, Champagne J, Paradis JM, O'Hara G, Muntané-Carol G, Alperi A, Faroux L, Junquera L, Rodés-Cabau J. Safety and effects of volume loading during transesophageal echocardiography in the pre-procedural work-up for left atrial appendage closure. Cardiovasc Ultrasound 2021;19:3. [PMID: 33388071 DOI: 10.1186/s12947-020-00230-1] [Reference Citation Analysis]
19 Munir MB, Khan MZ, Darden D, Pasupula DK, Balla S, Han FT, Reeves R, Hsu JC. Contemporary procedural trends of Watchman percutaneous left atrial appendage occlusion in the United States. J Cardiovasc Electrophysiol 2021;32:83-92. [PMID: 33155356 DOI: 10.1111/jce.14804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Khan SU, Khan MZ, Alkhouli M. Reader's Comments: Trends in the Utilization of Left Atrial Appendage Exclusion in the United States. Am J Cardiol 2020;126:106-7. [PMID: 32336535 DOI: 10.1016/j.amjcard.2020.03.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Osman M, Busu T, Osman K, Khan SU, Daniels M, Holmes DR, Alkhouli M. Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis. JACC Clin Electrophysiol 2020;6:494-506. [PMID: 32439033 DOI: 10.1016/j.jacep.2019.11.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wu Y, Zhang C, Gu ZC. Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting. Front Cardiovasc Med 2021;8:675200. [PMID: 34268343 DOI: 10.3389/fcvm.2021.675200] [Reference Citation Analysis]
23 Busu T, Khan SU, Alhajji M, Alqahtani F, Holmes DR, Alkhouli M. Observed versus Expected Ischemic and Bleeding Events Following Left Atrial Appendage Occlusion. Am J Cardiol 2020;125:1644-50. [PMID: 32273055 DOI: 10.1016/j.amjcard.2020.02.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
24 Alkhouli M, Chaker Z, Clemetson E, Alqahtani F, Al Hajji M, Lobban J, Sengupta PP, Raybuck B. Incidence, Characteristics and Management of Persistent Peri-Device Flow after Percutaneous Left Atrial Appendage Occlusion. Structural Heart 2019;3:491-8. [DOI: 10.1080/24748706.2019.1663381] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Reiffel JA. Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation. J Innov Card Rhythm Manag 2018;9:3446-52. [PMID: 32494480 DOI: 10.19102/icrm.2018.091201] [Reference Citation Analysis]
26 Holmes DR Jr, Alkhouli M. The History of the Left Atrial Appendage Occlusion. Card Electrophysiol Clin 2020;12:1-11. [PMID: 32067639 DOI: 10.1016/j.ccep.2019.11.009] [Reference Citation Analysis]
27 He B, Jiang LS, Hao ZY, Wang H, Miao YT. Combination of ablation and left atrial appendage closure as "One-stop" procedure in the treatment of atrial fibrillation: Current status and future perspective. Pacing Clin Electrophysiol 2021;44:1259-66. [PMID: 33629763 DOI: 10.1111/pace.14201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Alkhouli M. Moving the Needle Forward for More Relevant Evidence on Left Atrial Appendage Occlusion. JACC Cardiovasc Interv 2021;14:79-82. [PMID: 33413868 DOI: 10.1016/j.jcin.2020.10.044] [Reference Citation Analysis]
29 Anderson JL, Jacobs V, May HT, Bair TL, Benowitz BA, Lappe DL, Muhlestein JB, Knowlton KU, Bunch TJ. Free thyroxine within the normal reference range predicts risk of atrial fibrillation. J Cardiovasc Electrophysiol 2019;31:18-29. [DOI: 10.1111/jce.14183] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]